Brian McKelligon
2021
In 2021, Brian McKelligon earned a total compensation of $2.3M as Chief Executive Officer at Akoya Biosciences, a 339% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $173,599 |
|---|---|
| Option Awards | $1,700,389 |
| Salary | $393,333 |
| Total | $2,267,321 |
McKelligon received $1.7M in option awards, accounting for 75% of the total pay in 2021.
McKelligon also received $173.6K in non-equity incentive plan and $393.3K in salary.
Rankings
In 2021, Brian McKelligon's compensation ranked 5,546th out of 12,415 executives tracked by ExecPay. In other words, McKelligon earned more than 55.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,546 out of 12,415 | 55th |
Division Manufacturing | 2,346 out of 5,505 | 57th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 288 out of 801 | 64th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 88 out of 206 | 57th |
Industry Laboratory Analytical Instruments | 41 out of 90 | 54th |
Source: SEC filing on April 19, 2022.
McKelligon's colleagues
We found two more compensation records of executives who worked with Brian McKelligon at Akoya Biosciences in 2021.